BACKGROUND: Alzheimer's disease (AD) is one of the most common neurodegenerative diseases that causes problems related to brain function. To some extent it is understood on a molecular level how AD arises, however there are a lack of biomarkers that can be used for early diagnosis. Two popular methods to identify AD-related biomarkers use genetics and neuroimaging. Genes and neuroimaging phenotypes have provided some insights as to the potential for AD biomarkers. While the field of imaging-genomics has identified genetic features associated with structural and functional neuroimaging phenotypes, it remains unclear how variants that affect splicing could be important for understanding the genetic etiology of AD. METHODS: In this stud...
Late onset Alzheimer’s disease (LOAD), the most common cause of late onset dementia, has a strong ge...
Background: Alzheimer’s disease (AD) is a highly heritable disease, but until recently few replicat...
Aim: Late-onset Alzheimer’s disease (LOAD) accounts for 95% of all Alzheimer’s cases and is genetica...
Abstract Background Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases th...
Genetic variation in cis-regulatory elements related to splicing machinery and splicing regulatory e...
BACKGROUND: At least 90% of human genes are alternatively spliced. Alternative splicing has an im...
Alzheimer's disease (AD) is a common neurodegenerative disease in aging individuals. Alternative spl...
Objectives: A reduction in glucose metabolism in the posterior cingulate cortex (PCC) predicts conve...
Abstract Background At least 90% of human genes are alternatively spliced. Alternative splicing has ...
INTRODUCTION Despite increasing evidence of a role of rare genetic variation in the risk of Alzhe...
AbstractAlternative splicing is a highly regulated process which generates transcriptome and proteom...
The Alzheimer's Disease Sequencing Project (ADSP) undertook whole exome sequencing in 5,740 late-ons...
Familial Alzheimer's disease (AD), mostly associated with early onset, is caused by mutations in thr...
Aim: Late-onset Alzheimer's disease (LOAD) accounts for 95% of all Alzheimer's cases and is genetica...
Alzheimer’s disease (AD), the leading cause of dementia, has an estimated heritability of approximat...
Late onset Alzheimer’s disease (LOAD), the most common cause of late onset dementia, has a strong ge...
Background: Alzheimer’s disease (AD) is a highly heritable disease, but until recently few replicat...
Aim: Late-onset Alzheimer’s disease (LOAD) accounts for 95% of all Alzheimer’s cases and is genetica...
Abstract Background Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases th...
Genetic variation in cis-regulatory elements related to splicing machinery and splicing regulatory e...
BACKGROUND: At least 90% of human genes are alternatively spliced. Alternative splicing has an im...
Alzheimer's disease (AD) is a common neurodegenerative disease in aging individuals. Alternative spl...
Objectives: A reduction in glucose metabolism in the posterior cingulate cortex (PCC) predicts conve...
Abstract Background At least 90% of human genes are alternatively spliced. Alternative splicing has ...
INTRODUCTION Despite increasing evidence of a role of rare genetic variation in the risk of Alzhe...
AbstractAlternative splicing is a highly regulated process which generates transcriptome and proteom...
The Alzheimer's Disease Sequencing Project (ADSP) undertook whole exome sequencing in 5,740 late-ons...
Familial Alzheimer's disease (AD), mostly associated with early onset, is caused by mutations in thr...
Aim: Late-onset Alzheimer's disease (LOAD) accounts for 95% of all Alzheimer's cases and is genetica...
Alzheimer’s disease (AD), the leading cause of dementia, has an estimated heritability of approximat...
Late onset Alzheimer’s disease (LOAD), the most common cause of late onset dementia, has a strong ge...
Background: Alzheimer’s disease (AD) is a highly heritable disease, but until recently few replicat...
Aim: Late-onset Alzheimer’s disease (LOAD) accounts for 95% of all Alzheimer’s cases and is genetica...